Sensorion announces positive topline results from Seliforant Phase 2a study. pdfRead

Sensorion announces a publication in Hearing Research on kinetics of prestin blood levels after noise trauma-induced hearing loss. pdfRead

Sensorion announces completion of patient enrollment and dosing in Seliforant phase 2a study. pdfRead

Sensorion enters into exclusive negotiations with Pasteur Institute for hearing loss Gene Therapy programs. pdfRead

Sensorion announces presentation of SENS-401 poster at society for Neuroscience 2018 annual meeting. pdfRead

Next events